drugset / Trial / NCT01183585

A Study of RO4917838 With Rosuvastatin in Healthy Volunteers

NCT01183585

Phase 1 Completed 18 enrolled Hoffmann-La Roche
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This single centre, open-label study will investigate the effect of RO4917838 on the pharmacokinetics of Rosuvastatin, a frequently co-prescribed drug in healthy volunteers. Healthy volunteers will receive multiple oral doses of RO4917838 and single oral dose of Rosuvastatin.

Timeline

Start
2010-08
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule Oral
Subject bitopertin Small molecule Oral

Indications

No indication recorded.